Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8453 | 1182 | 40.3 | 80% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ORAL TOLERANCE | Author keyword | 169 | 46% | 24% | 278 |
2 | EPICUTANEOUS IMMUNIZATION | Author keyword | 13 | 67% | 1% | 12 |
3 | MUCOSAL TOLERANCE | Author keyword | 9 | 38% | 2% | 20 |
4 | NASAL TOLERANCE | Author keyword | 9 | 50% | 1% | 13 |
5 | BYSTANDER SUPPRESSION | Author keyword | 6 | 44% | 1% | 11 |
6 | ACTIVE SUPPRESSION | Author keyword | 5 | 55% | 1% | 6 |
7 | CONTRASUPPRESSION | Author keyword | 4 | 67% | 0% | 4 |
8 | ORAL IMMUNE REGULATION | Author keyword | 4 | 75% | 0% | 3 |
9 | ORAL ANTIGEN | Author keyword | 3 | 57% | 0% | 4 |
10 | PATIENT TRIAL | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ORAL TOLERANCE | 169 | 46% | 24% | 278 | Search ORAL+TOLERANCE | Search ORAL+TOLERANCE |
2 | EPICUTANEOUS IMMUNIZATION | 13 | 67% | 1% | 12 | Search EPICUTANEOUS+IMMUNIZATION | Search EPICUTANEOUS+IMMUNIZATION |
3 | MUCOSAL TOLERANCE | 9 | 38% | 2% | 20 | Search MUCOSAL+TOLERANCE | Search MUCOSAL+TOLERANCE |
4 | NASAL TOLERANCE | 9 | 50% | 1% | 13 | Search NASAL+TOLERANCE | Search NASAL+TOLERANCE |
5 | BYSTANDER SUPPRESSION | 6 | 44% | 1% | 11 | Search BYSTANDER+SUPPRESSION | Search BYSTANDER+SUPPRESSION |
6 | ACTIVE SUPPRESSION | 5 | 55% | 1% | 6 | Search ACTIVE+SUPPRESSION | Search ACTIVE+SUPPRESSION |
7 | CONTRASUPPRESSION | 4 | 67% | 0% | 4 | Search CONTRASUPPRESSION | Search CONTRASUPPRESSION |
8 | ORAL IMMUNE REGULATION | 4 | 75% | 0% | 3 | Search ORAL+IMMUNE+REGULATION | Search ORAL+IMMUNE+REGULATION |
9 | ORAL ANTIGEN | 3 | 57% | 0% | 4 | Search ORAL+ANTIGEN | Search ORAL+ANTIGEN |
10 | PATIENT TRIAL | 3 | 100% | 0% | 3 | Search PATIENT+TRIAL | Search PATIENT+TRIAL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DRIVEN BYSTANDER SUPPRESSION | 56 | 85% | 2% | 29 |
2 | TOLERIZATION | 42 | 62% | 4% | 43 |
3 | ORAL TOLERANCE | 34 | 14% | 19% | 222 |
4 | ACTIVE SUPPRESSION | 24 | 40% | 4% | 47 |
5 | RETINAL ANTIGENS SUPPRESSES | 21 | 90% | 1% | 9 |
6 | ADENOVIRAL ANTIGENS | 17 | 62% | 2% | 18 |
7 | DOSE ORAL TOLERANCE | 13 | 55% | 1% | 16 |
8 | MUCOSAL TOLERANCE | 10 | 37% | 2% | 21 |
9 | TCR TRANSGENIC MICE | 9 | 41% | 2% | 18 |
10 | FEEDING PROTEIN ANTIGENS | 9 | 83% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Oral tolerance | 2005 | 398 | 286 | 57% |
Oral tolerance: Immune mechanisms and treatment of autoimmune diseases | 1997 | 559 | 118 | 68% |
Immune responses to dietary antigens: oral tolerance | 1998 | 312 | 99 | 68% |
Therapeutic potential of oral tolerance | 2004 | 111 | 132 | 55% |
Oral tolerance | 2011 | 171 | 183 | 28% |
Oral tolerance: Therapeutic implications for autoimmune diseases | 2006 | 115 | 148 | 57% |
Oral tolerance: Mechanisms and therapeutic applications | 1999 | 193 | 459 | 52% |
Perspectives on mucosal vaccines: Is mucosal tolerance a barrier? | 2007 | 63 | 55 | 33% |
ORAL TOLERANCE - IMMUNOLOGICAL MECHANISMS AND TREATMENT OF ANIMAL AND HUMAN ORGAN-SPECIFIC AUTOIMMUNE-DISEASES BY ORAL-ADMINISTRATION OF AUTOANTIGENS | 1994 | 752 | 109 | 58% |
Oral tolerance for the treatment of autoimmune diseases | 1997 | 147 | 67 | 75% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIO DTU BIOCHEM NUTR | 2 | 67% | 0.2% | 2 |
2 | IMUNOBIOL | 2 | 19% | 0.8% | 9 |
3 | HUMAN DEV BIOL | 2 | 16% | 0.9% | 11 |
4 | ALERGIA IMUNOL CLIN EXPT LIM56 | 1 | 50% | 0.2% | 2 |
5 | ALIMENTARY TECHNOL | 1 | 100% | 0.2% | 2 |
6 | GRP IMUNOL GASTRINTESTINAL | 1 | 100% | 0.2% | 2 |
7 | BIOCHEM PROC DEV | 1 | 50% | 0.1% | 1 |
8 | BIOL CELULAR GENETPHLC | 1 | 50% | 0.1% | 1 |
9 | BIOL MOL BIOL CELL BIOL | 1 | 50% | 0.1% | 1 |
10 | CLIN BIOCHEM CHEM SCI | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000129267 | VET ANAT PATHOL B14//ACINAR CELL CULTURE//COMPREHENS CANC UNIV STN |
2 | 0.0000111851 | CCR9//CCL28//ANTIGEN P ENTAT GRP |
3 | 0.0000098845 | SECRETION INHIBITION//RNF13//PROTEASE ASSOCIATED DOMAIN |
4 | 0.0000089374 | CHOLERA TOXIN//HEAT LABILE ENTEROTOXIN//RECOMBINANT CHOLERA TOXIN B SUBUNIT RCTB |
5 | 0.0000086229 | INTESTINAL INTRAEPITHELIAL LYMPHOCYTES//INTRAEPITHELIAL LYMPHOCYTES//INTRAEPITHELIAL LYMPHOCYTE IEL |
6 | 0.0000075362 | ALLERGEN FRAGMENTS//AMPLIFICATION FREE//H2 GENOTYPE |
7 | 0.0000066795 | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS//MYELIN OLIGODENDROCYTE GLYCOPROTEIN//EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS |
8 | 0.0000066486 | SECT MED INFLAMMAT//COLLAGEN INDUCED ARTHRITIS//MED INFLAMMAT |
9 | 0.0000061385 | CANCER BIOTHERAPY//IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI//INTRACELLULAR IMMUNOFLUORESCENCE |
10 | 0.0000060799 | DEXTRAN SULFATE SODIUM//EXPERIMENTAL COLITIS//BIOL CHEM BIOACT |